Fairmount Healthcare Fund II L.P.: insider buys
Every open-market stock purchase reported by Fairmount Healthcare Fund II L.P. to the SEC on Form 4.
Total bought$32.38M
Purchases2
Companies2
Last purchase filedJul 20, 2026
Return on these buys+25%
Fairmount Healthcare Fund II L.P. has made 2 open-market purchases worth $32.38M in 2 companies since May 13, 2026, according to SEC Form 4 filings. The most recent was filed on Jul 20, 2026: 853,450 shares of CBIO at $14.50 (Director, 10% Owner), worth $12.38M. The largest was $20M of VRDN on May 11, 2026. Taken together, these purchases are up 25% at the latest closing prices (split-adjusted, weighted by amount).
Companies Fairmount Healthcare Fund II L.P. bought
| Ticker | Company | Role | Buys | Total | Since buy | Last filed |
|---|---|---|---|---|---|---|
| VRDN | Viridian Therapeutics, Inc.\DE | Director, 10% Owner | 1 | $20M | +45% | May 13 |
| CBIO | Crescent Biopharma, Inc. | Director, 10% Owner | 1 | $12.38M | -7.0% | Jul 20 |
Get the next Fairmount Healthcare Fund II L.P. purchase on TelegramFree daily recap of the biggest insider purchases, straight from SEC filings. Real-time alerts for Premium members.
Join free on TelegramAll purchases
| Filed | Stock | Insider | Value | Shares | Price | Since buy | Stake | Trade | |
|---|---|---|---|---|---|---|---|---|---|
| Jul 20 | CBIOCrescent Biopharma, Inc. | Fairmount Healthcare Fund II…Director, 10% Owner | $12.38M | 853,450 | $14.50 | -7.0% | +31% | Jul 16 | SEC |
| May 13 | VRDNViridian Therapeutics, Inc.\DE | Fairmount Healthcare Fund II…Director, 10% Owner | $20M | 1,176,470 | $17.00 | +45% | +30% | May 11 | SEC |